Anticancer activity of new organo-ruthenium, rhodium and iridium complexes containing the 2-(pyridine-2-yl)thiazole N,N-chelating ligand

Keyphrases

• Organo 100%
• Iridium Complex 100%
• Rhodium Complexes 100%
• Ruthenium Complexes 100%
• Anticancer Activity 100%
• Thiazole 100%
• Pyridine-2 100%
• N,N-chelating Ligands 100%
• Arenes 50%
• Ru(II) Complexes 50%
• Dinuclear 33%
• Chloride Salt 33%
• Benzene 16%
• Tin Chloride 16%
• Metal Complexes 16%
• Molecular Structure 16%
• X-ray Crystal Structure Analysis 16%
• Ubiquitin 16%
• Hexafluorophosphate 16%
• Cationic Complexes 16%
• Model Proteins 16%
• Ovarian Cancer Cells 16%
• Human Ovarian Cancer Cell 16%
• Plasmid DNA (pDNA) 16%
• Cisplatin Resistance 16%
• In Vitro Anticancer Activity 16%
• Heterometallic 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Rhodium Complex 100%
• Ruthenium Complex 100%
• Iridium Complex 100%
• Thiazole 100%
• Polycyclic Aromatic Hydrocarbon 50%
• Cisplatin 16%
• Hexafluorophosphate 16%
• Ovary Cancer 16%
• Metal Complex 16%
• Plasmid DNA 16%
• Ubiquitin 16%

Chemistry

• Rhodium 100%
• Iridium 100%
• Ruthenium 100%
• Thiazole 100%
• Chloride Salt 33%
• Single Crystalline Solid 16%
• Molecular Structure 16%
• Cisplatin 16%
• DNA 16%
• Ubiquitins 16%
• Plasmid 16%